Astera Labs (NASDAQ:ALAB) Downgraded by Wall Street Zen to “Hold”

Wall Street Zen downgraded shares of Astera Labs (NASDAQ:ALAB) from a buy rating to a hold rating in a research note issued to investors on Friday.

ALAB has been the topic of a number of other research reports. Jefferies Financial Group increased their price target on Astera Labs from $95.00 to $130.00 and gave the stock a “buy” rating in a research note on Tuesday, July 22nd. CICC Research initiated coverage on Astera Labs in a research report on Friday, August 29th. They set an “outperform” rating and a $190.00 target price on the stock. Susquehanna raised their price target on Astera Labs from $80.00 to $125.00 and gave the stock a “neutral” rating in a research note on Thursday, August 7th. Bank of America started coverage on shares of Astera Labs in a research note on Friday. They set a “neutral” rating and a $230.00 price objective for the company. Finally, Weiss Ratings reissued a “hold (c-)” rating on shares of Astera Labs in a research report on Saturday, September 27th. One research analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and seven have given a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $159.83.

Astera Labs Stock Down 4.2%

NASDAQ:ALAB opened at $200.74 on Friday. Astera Labs has a 52-week low of $47.13 and a 52-week high of $262.90. The stock has a fifty day simple moving average of $189.83 and a 200-day simple moving average of $119.14. The company has a market capitalization of $33.37 billion, a PE ratio of 358.46, a price-to-earnings-growth ratio of 5.32 and a beta of 1.43.

Astera Labs (NASDAQ:ALAB) last posted its earnings results on Tuesday, August 5th. The company reported $0.44 earnings per share for the quarter, beating the consensus estimate of $0.33 by $0.11. Astera Labs had a net margin of 16.54% and a return on equity of 9.53%. The firm had revenue of $191.93 million during the quarter, compared to the consensus estimate of $172.46 million. During the same period last year, the firm posted $0.13 EPS. The firm’s revenue for the quarter was up 149.5% on a year-over-year basis. Astera Labs has set its Q3 2025 guidance at 0.380-0.390 EPS. As a group, equities analysts anticipate that Astera Labs will post 0.34 earnings per share for the current year.

Insider Activity

In other Astera Labs news, COO Sanjay Gajendra sold 280,000 shares of the company’s stock in a transaction dated Thursday, August 7th. The shares were sold at an average price of $170.02, for a total value of $47,605,600.00. Following the completion of the transaction, the chief operating officer directly owned 5,525,545 shares of the company’s stock, valued at $939,453,160.90. This represents a 4.82% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, CFO Michael Truett Tate sold 100,000 shares of Astera Labs stock in a transaction dated Thursday, August 7th. The stock was sold at an average price of $171.38, for a total value of $17,138,000.00. Following the sale, the chief financial officer directly owned 518,996 shares in the company, valued at approximately $88,945,534.48. The trade was a 16.16% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 1,492,036 shares of company stock worth $232,607,552. 12.50% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Astera Labs

Institutional investors have recently made changes to their positions in the business. Great Valley Advisor Group Inc. increased its stake in shares of Astera Labs by 2.2% in the second quarter. Great Valley Advisor Group Inc. now owns 4,119 shares of the company’s stock worth $372,000 after buying an additional 90 shares during the last quarter. Straight Path Wealth Management grew its holdings in Astera Labs by 1.5% during the 2nd quarter. Straight Path Wealth Management now owns 6,850 shares of the company’s stock worth $619,000 after acquiring an additional 100 shares in the last quarter. First Horizon Advisors Inc. increased its position in shares of Astera Labs by 12.4% in the 2nd quarter. First Horizon Advisors Inc. now owns 982 shares of the company’s stock worth $89,000 after purchasing an additional 108 shares during the last quarter. Advisors Asset Management Inc. raised its stake in shares of Astera Labs by 68.6% in the 2nd quarter. Advisors Asset Management Inc. now owns 477 shares of the company’s stock valued at $43,000 after purchasing an additional 194 shares in the last quarter. Finally, Hoey Investments Inc. lifted its position in shares of Astera Labs by 4.2% during the first quarter. Hoey Investments Inc. now owns 5,000 shares of the company’s stock worth $298,000 after purchasing an additional 200 shares during the last quarter. 60.47% of the stock is owned by institutional investors and hedge funds.

Astera Labs Company Profile

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.